0001214659-22-003836.txt : 20220309 0001214659-22-003836.hdr.sgml : 20220309 20220309182624 ACCESSION NUMBER: 0001214659-22-003836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220307 FILED AS OF DATE: 20220309 DATE AS OF CHANGE: 20220309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kazam Joshua A CENTRAL INDEX KEY: 0001221355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 22726748 MAIL ADDRESS: STREET 1: 689 5TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHUA A DATE OF NAME CHANGE: 20070920 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHOA A DATE OF NAME CHANGE: 20030303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-55743.xml PRIMARY DOCUMENT X0306 4 2022-03-07 0001737287 Allogene Therapeutics, Inc. ALLO 0001221355 Kazam Joshua A 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false Common Stock 2022-03-07 4 J false 412618 0.0 A 671503 D Common Stock 2022-03-07 4 G false 412618 0.0 D 258885 D The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein. /s/ Veer Bhavnagri, Attorney-in-Fact 2022-03-09